| 标题 |
Felzartamab plus lenalidomide–dexamethasone versus lenalidomide–dexamethasone for relapsed or refractory multiple myeloma: an open-label, parallel-controlled, randomised, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Haematology 作者:Haiyan He; Jingjing Shang; Yafei Wang; Zhongjun Xia; Fangbing Zhu; et al 出版日期:2026-10-01 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)